Sana Biotechnology, Inc. Common Stock SANA
$3.13
+1.29%
at last close
Market Cap$925.02 million
P/E Ratio—
Div Yield—
Volume3.28M
52-Week Range
$2.61$6.55
Analyst Ratings
- Consensus
- Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $7.00 (+123.6% upside)
Key Stats
- Today's Range
- $3.01 – $3.17
- 50-Day Range
- $3.00 – $4.21
- 52-Week Range
- $2.61 – $6.55
- Volume
- 3.28 million shs
- Average Volume
- 2.81 million shs
- Market Cap
- $925.02 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 5.98
- Price / Sales
- —
Short Interest
- Short Interest
- 0.18%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- —
- Net Income
- $-211,822,000
- Net Margin
- —
- Return on Equity
- -137.04%
- Debt-to-Equity
- —
About Sana Biotechnology, Inc. Common Stock
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Related Stocks
Compare head-to-head: SANA vs AMGN·SANA vs MRNA·SANA vs HALO·SANA vs KRYS
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.